+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Hereditary Angioedema Market Report and Forecast 2025-2034 - Product Thumbnail Image

Hereditary Angioedema Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
From
Ischemic Stroke Market Report and Forecast 2024-2032 - Product Thumbnail Image

Ischemic Stroke Market Report and Forecast 2024-2032

  • Report
  • May 2024
  • 160 Pages
  • Global
From
Anti-Hypertensive Drug Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Anti-Hypertensive Drug Market - Forecasts from 2025 to 2030

  • Report
  • January 2025
  • 144 Pages
  • Global
From
Anticoagulants Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Anticoagulants Market - Forecasts from 2025 to 2030

  • Report
  • January 2025
  • 144 Pages
  • Global
From
Atrial Septal Defect Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Atrial Septal Defect Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 146 Pages
  • Global
From
Heparin Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Heparin Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 140 Pages
  • Global
From
Aspirin Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Aspirin Market - Forecasts from 2022 to 2027

  • Report
  • August 2022
  • 140 Pages
  • Global
From
From
From
From
From
Acute Decompensated Heart Failure - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Acute Decompensated Heart Failure - Global Clinical Trials Review, 2025

  • Clinical Trials
  • March 2025
  • 191 Pages
  • Global
From
Acute coronary syndrome: Competitive Landscape - Product Thumbnail Image

Acute coronary syndrome: Competitive Landscape

  • Report
  • August 2024
  • 79 Pages
  • Global
From
Dyslipidemia - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Dyslipidemia - Global Clinical Trials Review, 2024

  • Clinical Trials
  • June 2024
  • 1761 Pages
  • Global
From
Hypercholesterolemia - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Hypercholesterolemia - Global Clinical Trials Review, 2024

  • Clinical Trials
  • May 2024
  • 1282 Pages
  • Global
From
Acute Ischemic Stroke (AIS) - Competitive Landscape - Product Thumbnail Image

Acute Ischemic Stroke (AIS) - Competitive Landscape

  • Report
  • December 2023
  • 77 Pages
  • Global
From
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more